Doctor profile · Federal record
Dr. KATIE JOSHI, PA-C
Medical Physician Assistant (CMS: PHYSICIAN ASSISTANT) · Medical Physician Assistant · ALBUQUERQUE, NM
- NPI 1417144890
- Accepts Medicare
- 19 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5400 GIBSON BLVD SE
ALBUQUERQUE, NM 871084729
(505) 262-3560
fax (505) 262-7729
Credentials & registration
- NPI registered
- September 2007 — 19 yrs on file
- Profile last updated
- September 13, 2011
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State licenses (2)
- New Mexico #PA2011-0017 · Pennsylvania #MA053086
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1417144890. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,507
Distinct HCPCS
8
Medicare allowed
$67,007
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 654 | 125 | $5 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 285 | 219 | $103 | |
17000 |
Destruction of precancer skin growth, 1 growth | 218 | 165 | $43 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 137 | 113 | $73 | |
11102 |
Biopsy of related skin growth, first growth | 131 | 116 | $79 | |
11103 |
Biopsy of related skin growth, each additional growth | 37 | 32 | $40 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 25 | 23 | $45 | |
17110 |
Destruction of skin growth, 1-14 growths | 20 | 19 | $90 |
In context: peer comparison
Among 43 peers in this city , average services per provider: 189. This provider delivers 8.0× the peer median.Open Payments
Industry payments received
All-time total
$1,337
Transactions
50
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 9 | $371.38 | |
| GENZYME CORPORATION | 8 | $190.23 | |
| ABBVIE INC. | 11 | $178.46 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $85.13 | |
| Amgen Inc. | 3 | $73.66 | |
| PFIZER INC. | 1 | $70.44 | |
| Incyte Corporation | 3 | $62.45 | |
| Lilly USA, LLC | 3 | $59.17 | |
| Galderma Laboratories, L.P. | 3 | $54.03 | |
| Novartis Pharmaceuticals Corporation | 2 | $52.48 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $39.69 | |
| UCB, Inc. | 2 | $35.61 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17.49 | |
| Organon Llc | 1 | $17.09 | |
| LEO Pharma Inc. | 1 | $16.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
223
Patients
71
Total drug cost
$6,654
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 64 | 0 | $1,598 |
| Triamcinolone Acetonide | Generic | 44 | 33 | $248 |
| Fluorouracil | Generic | 28 | 25 | $1,731 |
| Clobetasol Propionate | Generic | 20 | 0 | $1,373 |
| Ketoconazole | Generic | 20 | 0 | $184 |
| Betamethasone Dipropionate | Generic | 17 | 13 | $727 |
| Hydroxyzine Hcl | Generic | 16 | 0 | $144 |
| Spironolactone | Generic | 14 | 0 | $649 |